Department of Neurosurgery, Sri Chitra Tirunal Institute for Medical Science and Technology, Medical College Post, Trivandrum, 695011, Kerala, India.
Department of Neurosurgery, Sri Chitra Tirunal Institute for Medical Science and Technology, Medical College Post, Trivandrum, 695011, Kerala, India.
Clin Neurol Neurosurg. 2020 May;192:105711. doi: 10.1016/j.clineuro.2020.105711. Epub 2020 Feb 3.
The optimal therapeutic approach to craniopharyngioma has not been established conclusively. The surgical outcome following radical excision and conservative resection with adjuvant radiotherapy are comparable or even better with the later in pediatric or mixed populations. This study is aimed at reviewing the role of extent of resection in local tumor control and long-term outcome in adults with craniopharyngioma.
Ninety-five adults operated between 2001 and 2013 were included. Progression-free survival (PFS) and overall survival (OS) were calculated. Predictors of various outcome parameters were analyzed.
The predominant presenting symptom was visual impairment (78 %) followed by symptoms of hypothalamic involvement (29 %). Total and subtotal excisions (TE, STE) were achieved in 63 %, and 47 % of patients, respectively. Vision improved in 62 % of patients in the early postoperative period. Thirteen patients (14 %) experienced vision deterioration postoperatively. On multivariate analysis, tumor >3 cm and optic atrophy predicted poor visual outcome. Hormonal replacement for hypopituitarism was required in 83 % during follow-up. Diabetes insipidus was seen in 73 %. Imaging evidence of 3rd ventricular floor destruction by tumor emerged as an independent predictor of postoperative hypothalamic morbidities. The recurrence rate following TE and STE was 11.6 % and 72 %, respectively. Unlike radical excision, PFS following STE was significantly shorter (p- 0.02). TE was not associated with increased visual impairment or hypothalamic-pituitary dysfunction postoperatively as compared to STE. Most of the patients (85 %) were independent and able to return to the premorbid occupation.
Subtotal resection provides equally good long-term visual, endocrinological, and hypothalamic outcomes as radical surgery. When used with adjuvant radiotherapy, it also gives a better local control of the tumor. Hence, subtotal resection with adjuvant radiotherapy should be considered as an effective alternative strategy to radical excision.
颅咽管瘤的最佳治疗方法尚未确定。在儿科或混合人群中,根治性切除加辅助放疗的手术结果与后者相当甚至更好。本研究旨在回顾颅咽管瘤患者的肿瘤切除范围与局部肿瘤控制和长期预后的关系。
纳入了 2001 年至 2013 年间接受手术的 95 例成人患者。计算无进展生存期(PFS)和总生存期(OS)。分析了各种结果参数的预测因素。
最常见的首发症状是视力障碍(78%),其次是下丘脑受累症状(29%)。63%和 47%的患者分别行全切除和次全切除术(TE、STE)。术后早期,62%的患者视力改善。术后 13 例(14%)患者视力恶化。多变量分析显示,肿瘤>3cm 和视神经萎缩预测视力不良。随访期间,83%的患者需要补充垂体激素。73%的患者出现尿崩症。肿瘤破坏第三脑室底是术后下丘脑并发症的独立预测因素。TE 和 STE 后的复发率分别为 11.6%和 72%。与根治性切除不同,STE 后的 PFS 明显缩短(p=0.02)。与 STE 相比,TE 术后并不会增加视力损害或下丘脑-垂体功能障碍。大多数患者(85%)术后能够独立并恢复到患病前的职业状态。
次全切除与根治性手术同样能提供良好的长期视力、内分泌和下丘脑结局。与辅助放疗联合应用时,还能更好地控制肿瘤的局部进展。因此,次全切除加辅助放疗应被视为根治性切除的有效替代策略。